Results 181 to 190 of about 118,618 (295)

Prognostic significance of receptor conversion following neoadjuvant therapy in breast cancer: a systematic review & meta-analysis. [PDF]

Breast
Dowling GP, Daly GR, Hehir CM, AlRawasdeh MM, Calpin GG, Almasri S, Toomey S, Young LS, Hennessey BT, Hill ADK.   +9 more
europepmc   +1 more source

Preeclampsia and risk of breast cancer: A longitudinal cohort study of tumor histology

International Journal of Cancer, EarlyView.
What's New? Preeclampsia is protective against breast cancer, but it is not clear if the effect extends to all breast tumors. This study examined the association between preeclampsia and breast tumor histology. The findings suggest that the protective effect of preeclampsia is concentrated among ductal and lobular tumors, but not other tumors. Patients
Shu Qin Wei, Valérie Leduc, Brian Potter, Gilles Paradis, Aimina Ayoub, Jessica Healy‐Profitós, Amanda Maniraho, Antoine Lewin, Nathalie Auger   +8 more
wiley   +1 more source

Neoadjuvant Therapy [PDF]

JAMA Oncology, 2015
Jill O Jin, Howard Jack West
openaire   +2 more sources

Evolution of HER2 expression after neoadjuvant therapy in locally advanced gastric cancer. [PDF]

iScience
He J, Liu H, Dong Y, Hu C, Liang H, Shou D, Cao D, Du Y, Shao X, Lu Y, Wang H, Tuo C, Deng J, Zhang R, Wang X, Li B, Zhong N, Liu Y, Zhong Y, Gong W.   +19 more
europepmc   +1 more source

Multifactorial construction of low‐grade and high‐grade endometrial cancer recurrence prediction models

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Objective To analyze independent risk factors for endometrial cancer (EC), a common female cancer globally, and construct individualized prediction models for EC recurrence. Methods The EC patients from the medical record system were divided into low‐grade (n = 392) and high‐grade (n = 183) groups.
Yachai Li, Jia Yan, Yuanmei Deng, Peixuan Wang, Xue Bai, Wei Qin   +5 more
wiley   +1 more source

Complications after oesophagectomy with possible contribution of neoadjuvant therapy including an EGFR-antibody to a fatal outcome [PDF]

, 2007
Michael Knauer, A. Haid, Karlheinz Ammann, Alois Lang, Felix Offner, Martina Türtscher, Peter Cerkl, E. Wenzl   +7 more
openalex   +1 more source

Prospects for the application of pathological response rate in neoadjuvant therapy for gastric cancer. [PDF]

Front Oncol
Bao Z, Jia N, Zhang Z, Hou C, Yao B, Li Y.   +5 more
europepmc   +1 more source

Worldwide barriers of optimal surgical care provision in advanced ovarian cancer

International Journal of Gynecology &Obstetrics, EarlyView.
Abstract Ovarian cancer (OC) remains one of the most challenging gynecological malignancies to cure, despite recent advances in treatment. Disparities in the diagnosis, management, and survival of OC exist worldwide and addressing them remains an ongoing challenge.
Shriya Varghese, Myong Cheol Lim, Robert Armbrust, Rene Pareja, Christina Fotopoulou   +4 more
wiley   +1 more source

Neoadjuvant endocrine therapy: clinical and biological issues [PDF]

, 2007
IE Smith
openalex   +1 more source

Impact of Mutation Profile on Outcomes of Neoadjuvant Therapy in GIST. [PDF]

Cancers (Basel)
Mohammadi M, Roets E, Bleckman RF, Oosten AW, Grunhagen D, Desar IME, Bonenkamp H, Reyners AKL, van Etten B, Hartgrink H, Fiocco M, Schrage Y, Steeghs N, Gelderblom H.   +13 more
europepmc   +1 more source